跳至主要内容
临床试验/NCT03218293
NCT03218293已完成不适用

The Recovery of Nerve Function Deficient of Combined Intravenous Thrombolysis and Remote Ischemic Post-conditioning in Acute Ischemic Stroke.

First Affiliated Hospital Xi'an Jiaotong University1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2017年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
68
试验地点
1
主要终点
the percentage of patients with a favorable outcome, defined as a score of 0 or 1 on the modified Rankin scale (mRS).

研究概览

简要总结

Remote ischemic postconditioning (RIPC) is suggested to protect the cerebral cell against ischemia in various settings. However, the effect of RIPC in patients with acute ischemic stroke who undergo thrombolysis has yet to be examined. In this single-center, randomized controlled trial, we examined the effect of RIPC on the resolution of nerve function deficient in response to thrombolysis. Patients in the RIPC group had five cycles of 5-min cuff inflation followed by 3-min deflation to the bilateral upper arm after thrombolysis. The primary endpoint was the recovery of nerve function deficient assessed by National Institutes of Health Stroke Scale(NIHSS), Activities of Daily Living(ADL), Modified Rankin Scale(mRS), CT cerebral perfusion imaging (CTP) and CT angiography(CTA). Secondary endpoints included the following: angiogenesis assessed by the level of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •In accordance with the Guideline of Thrombolysis in Acute Ischemic Stroke and accomplish intravenous thrombolytic therapy using alteplase;
  • •The consciousness of patients are conscious,somnolence,confusion and stupor,can comply better with the RIPC treatment;
  • •Acute ischemic stroke confirmed by cranial CT/MRI;
  • •Provision of written informed consent.

排除标准

  • •History of cerebral embolism,cerebral hemorrhage, brain tumor, brain trauma or other brain lesion;
  • •Severe cardiac, liver, or kidney disease, malignancy, systemic organ dysfunction;
  • •Blood pressure <90/60 mmHg or >200/110 mmHg after treatment;
  • •Dementia or mental illness;
  • •History of major surgery or trauma 4 weeks prior to admission;
  • •Failure to provide informed consent.

研究组 & 干预措施

RIPC

Experimental

Remote ischemic postconditioning(RIPC):Patients in the RIPC group not only receive foundational treatment but also have five cycles of 5-min cuff inflation followed by 3-min deflation to the bilateral upper arm using a RIPC device (IPC-906X; Beijing Renqiao Institute of Neuroscience, Beijing, China) after thrombolysis while in-hospital.

干预措施: RIPC device (IPC-906X) (Device)

Blank control group(BC)

No Intervention

Blank control group:Patients in the BC group only receive foundational treatment, including free radical elimination in the acute stage, blood pressure and blood glucose stabilization, and antiplatelet (aspirin, 100-300 mg/d) and lipid-lowering (atorvastatin, 20 mg/d) drugs,throughout the 14 days in-hospital period without remote ischemic postconditioning after thrombolysis.

结局指标

主要结局

the percentage of patients with a favorable outcome, defined as a score of 0 or 1 on the modified Rankin scale (mRS).

时间窗: Day 90

次要结局

  • the percentage of functional recovery at discharge and at day 90, as measured by the NIHSS, the Barthel index (BI) and the mRS(Day 90 and at discharge(up to day 14))
  • Plasma biomarker concentrations(Day 1 and at discharge ( up to day 14))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验